RD Biomed, the Hull-based medical technology company, will launch a study with over 1,000 patients in China to measure the effectiveness of its reflux diagnostic device Peptest.
from The Medical News http://ift.tt/1AoPRjo
from The Medical News http://ift.tt/1AoPRjo
No comments:
Post a Comment